학술논문
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma
Document Type
article
Author
Source
Haematologica, Vol 108, Iss 12 (2023)
Subject
Language
English
ISSN
0390-6078
1592-8721
1592-8721